Table 2 Comparison of clinicopathological characteristics between MVI-positive and negative group after PSM
Variables | MVI-negative group | MVI-positive group | P-value | Total |
|---|---|---|---|---|
(N = 151) | (N = 78) | (N = 229) | ||
Age, year | ||||
  < 60 | 102 (67.5%) | 52 (66.7%) | 1.000 | 154 (67.2%) |
  ≥ 60 | 49 (32.5%) | 26 (33.3%) |  | 75 (32.8%) |
Sex | ||||
 Male | 86 (57.0%) | 42 (53.8%) | 0.758 | 128 (55.9%) |
 Female | 65 (43.0%) | 36 (46.2%) |  | 101 (44.1%) |
Hepatitis | ||||
 No | 94 (62.3%) | 51 (65.4%) | 0.748 | 145 (63.3%) |
 Yes | 57 (37.7%) | 27 (34.6%) |  | 84 (36.7%) |
Child-Pugh grade | ||||
 Stage A | 132 (87.4%) | 66 (84.6%) | 0.701 | 198 (86.5%) |
 Stage B | 19 (12.6%) | 12 (15.4%) |  | 31 (13.5%) |
Total bilirubin, μmol/L | ||||
  ≤ 20 | 95 (62.9%) | 48 (61.5%) | 0.952 | 143 (62.4%) |
  > 20 | 56 (37.1%) | 30 (38.5%) |  | 86 (37.6%) |
CA199, U/mL | ||||
 < 200 | 111 (73.5%) | 58 (74.4%) | 1.000 | 169 (73.8%) |
 ≥200 | 40 (26.5%) | 20 (25.6%) |  | 60 (26.2%) |
CEA, μg/L | ||||
  < 5 | 100 (66.2%) | 51 (65.4%) | 1.000 | 151 (65.9%) |
  ≥ 5 | 51 (33.8%) | 27 (34.6%) |  | 78 (34.1%) |
Operative bleeding loss, ml | ||||
  ≥ 800 | 118 (78.1%) | 56 (71.8%) | 0.367 | 174 (76.0%) |
  < 800 | 33 (21.9%) | 22 (28.2%) |  | 55 (24.0%) |
Blood transfusion | ||||
 No | 527 (84.6%) | 69 (85.2%) | 1.000 | 596 (84.7%) |
 Yes | 96 (15.4%) | 12 (14.8%) |  | 108 (15.3%) |
Laparoscopy | ||||
 Yes | 142 (94.0%) | 73 (93.6%) | 1.000 | 215 (93.9%) |
 No | 9 (6.0%) | 5 (6.4%) |  | 14 (6.1%) |
Lymph node dissection | ||||
 No | 80 (53.0%) | 43 (55.1%) | 0.866 | 123 (53.7%) |
 Yes | 71 (47.0%) | 35 (44.9%) |  | 106 (46.3%) |
Major hepatectomy | ||||
 No | 48 (31.8%) | 24 (30.8%) | 0.994 | 72 (31.4%) |
 Yes | 103 (68.2%) | 54 (69.2%) |  | 157 (68.6%) |
Tumor diameter, cm | ||||
  ≤ 5 | 43 (28.5%) | 22 (28.2%) | 1.000 | 65 (28.4%) |
  > 5 | 108 (71.5%) | 56 (71.8%) |  | 164 (71.6%) |
Tumor number | ||||
 Single | 88 (58.3%) | 47 (60.3%) | 0.883 | 135 (59.0%) |
 Multiple | 63 (41.7%) | 31 (39.7%) |  | 94 (41.0%) |
Satellite nodules | ||||
 No | 89 (58.9%) | 46 (59.0%) | 1.000 | 135 (59.0%) |
 Yes | 62 (41.1%) | 32 (41.0%) |  | 94 (41.0%) |
Surgical margin width, cm | ||||
  < 1 | 107 (70.9%) | 51 (65.4%) | 0.485 | 158 (69.0%) |
  ≥ 1 | 44 (29.1%) | 27 (34.6%) |  | 71 (31.0%) |
Differentiation | ||||
 Moderate or high | 108 (71.5%) | 54 (69.2%) | 0.835 | 162 (70.7%) |
 Poor | 43 (28.5%) | 24 (30.8%) |  | 67 (29.3%) |
Lymph node metastasis | ||||
 No | 111 (73.5%) | 57 (73.1%) | 1.000 | 168 (73.4%) |
 Yes | 40 (26.5%) | 21 (26.9%) |  | 61 (26.6%) |
Hepatolith | ||||
 No | 142 (94.0%) | 74 (94.9%) | 1.000 | 216 (94.3%) |
 Yes | 9 (6.0%) | 4 (5.1%) |  | 13 (5.7%) |
Postoperative hospital stay, day | ||||
  < 15 | 63 (41.7%) | 34 (43.6%) | 0.897 | 97 (42.4%) |
  ≥ 15 | 88 (58.3%) | 44 (56.4%) |  | 132 (57.6%) |